Literature DB >> 24483989

Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma.

Seung Up Kim1, Kyu Sik Jung, Sarah Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Gi Hong Choi, Kyung Sik Kim, Jin Sub Choi, Kwang-Hyub Han, Young Nyun Park.   

Abstract

BACKGROUND: Recurrence of hepatocellular carcinoma (HCC) after curative resection continues to be a major cause of death. This prospective study is designed to investigate whether histological subclassification of cirrhosis using the Laennec system could predict recurrence in patients with hepatitis B virus (HBV)-related HCC after curative resection.
METHODS: Patients with HBV-related HCC who underwent curative resection and showed Laennec stage 3 to 4 were enrolled and the cases with stage 4 were subclassified histologically into three groups (stages 4A, 4B and 4C) according to the Laennec system. Between February 2006 and August 2009, 92 patients were recruited.
RESULTS: Stage 3, 4A, 4B and 4C were identified in 24 (26.1%), 15 (16.3%), 43 (46.7%) and 10 (10.9%) patients respectively. The cumulative incidence rates of recurrence at 1, 2 and 3 years were 24.2%, 40.5% and 55.1% respectively. On multivariate analysis, serum albumin [hazard ratio (HR), 0.528; 95% confidence interval (CI), 0.312-0.891; P=0.017] and Edmondson-Steiner grade III-IV (HR, 3.456; 95% CI, 1.123-10.517; P=0.031) were significantly correlated with early recurrence (<1 year), whereas stage 4C (HR, 5.426; 95% CI, 1.030-28.598; P=0.046) was the only independent risk factor for late recurrence (≥1 year).
CONCLUSIONS: Histological subclassification of cirrhosis using the Laennec system is a significant predictor of late recurrence in patients with HBV-related HCC after curative resection.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  chronic hepatitis B; cirrhosis; fibrosis; hepatitis B virus; hepatocellular carcinoma; laennec staging; recurrence; resection

Mesh:

Year:  2014        PMID: 24483989     DOI: 10.1111/liv.12475

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  15 in total

1.  Clinicopathological Characteristics of Hepatocellular Carcinoma with Microscopic Portal Venous Invasion and the Role of Anatomical Liver Resection in These Cases.

Authors:  Shingo Shimada; Toshiya Kamiyama; Hideki Yokoo; Tatsuya Orimo; Kenji Wakayama; Takahiro Einama; Tatsuhiko Kakisaka; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

2.  Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting.

Authors:  Dustin E Bosch; Yoh Zen; Sarag A Boukhar; Yongjun Liu; Lin Cheng; Matthew M Yeh
Journal:  Virchows Arch       Date:  2021-08-20       Impact factor: 4.064

3.  Artificial Neural Network Model for Liver Cirrhosis Diagnosis in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Rong-Yun Mai; Jie Zeng; Yi-Shuai Mo; Rong Liang; Yan Lin; Su-Su Wu; Xue-Min Piao; Xing Gao; Guo-Bin Wu; Le-Qun Li; Jia-Zhou Ye
Journal:  Ther Clin Risk Manag       Date:  2020-07-17       Impact factor: 2.423

Review 4.  Severity of liver cirrhosis: a key role in the selection of surgical modality for Child-Pugh A hepatocellular carcinoma.

Authors:  Er-lei Zhang; Bin-yong Liang; Xiao-ping Chen; Zhi-yong Huang
Journal:  World J Surg Oncol       Date:  2015-04-15       Impact factor: 2.754

5.  Expression and Significances of G-Protein-Coupled Receptor Kinase 3 in Hepatocellular Carcinoma.

Authors:  Ye Jin; Zhi-Yong Liang; Wei-Xun Zhou; Li Zhou
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

Review 6.  Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy.

Authors:  Bogdan Procopet; Annalisa Berzigotti
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-17

7.  Real-world study on clinical outcomes of nucleos(t)ide analogues antiviral therapy in patients with chronic hepatitis B.

Authors:  Y Sun; Y Zhang; Y Xu; M Shu; K Bonroy; H Qiu; W Cai
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

8.  Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.

Authors:  Hye Soo Kim; Seung Up Kim; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Young Nyun Park; Dai Hoon Han; Kyung Sik Kim; Jin Sub Choi; Gi Hong Choi; Hyon-Suk Kim
Journal:  Clin Mol Hepatol       Date:  2019-06-27

9.  Analysis of Hepatic Fibrosis Characteristics in Cirrhotic Patients with and without Hepatocellular Carcinoma by FTIR Spectral Imaging.

Authors:  Johanna Moreau; Pascaline Bouzy; Julien Guillard; Valérie Untereiner; Roselyne Garnotel; Aude Marchal; Cyril Gobinet; Christine Terryn; Ganesh D Sockalingum; Gérard Thiéfin
Journal:  Molecules       Date:  2020-09-07       Impact factor: 4.411

10.  Sub-Classification of Cirrhosis Affects Surgical Outcomes for Early Hepatocellular Carcinoma Independent of Portal Hypertension.

Authors:  Er-Lei Zhang; Jiang Li; Jian Li; Wen-Qiang Wang; Jin Gu; Zhi-Yong Huang
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.